No black box warning on record for Enalapril Maleate

As of the latest FDA labeling reviewed, Enalapril Maleate (ENALAPRIL MALEATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Enalapril Maleate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including enalapril maleate) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of the face, extremities,

No black box warning on record for Enalapril Maleate

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including enalapril maleate) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of the face, extremities,

Enalapril Maleate Black Box Warning

No black box warning on record for Enalapril Maleate

Other warnings & precautions

Enalapril Maleate Black Box Warning

No black box warning on record for Enalapril Maleate

Other warnings & precautions